The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
CGRP and the Trigeminal System in Migraine
Open accessAbstract
Objective: The goal of this narrative review is to provide an overview of migraine pathophysiology, with an emphasis on the role of calcitonin gene‐related peptide (CGRP) within the context of the trigeminovascular system. Background: Migraine is a prevalent and disabling neurological disease that is characterized in part by intense, throbbing, and unilateral headaches. Despite recent advances in understanding its pathophysiology, migraine still represents an unmet medical need, as it is often underrecognized and undertreated. Although CGRP has been known to play a pivotal role in migraine for the last 2 decades, this has now received more interest spurred by the early clinical successes of drugs that block CGRP signaling in the trigeminovascular system. Design: This narrative review presents an update on the role of CGRP within the trigeminovascular system. PubMed searches were used to find recent (ie, 2016 to November 2018) published articles presenting new study results. Review articles are also included not as primary references but to bring these to the attention of the reader. Original research is referenced in describing the core of the narrative, and review articles are used to support ancillary points. Results: The trigeminal ganglion neurons provide the connection between the periphery, stemming from the interface between the primary afferent fibers of the trigeminal ganglion and the meningeal vasculature and the central terminals in the trigeminal nucleus caudalis. The neuropeptide CGRP is abundant in trigeminal ganglion neurons, and is released from the peripheral nerve and central nerve terminals as well as being secreted within the trigeminal ganglion. Release of CGRP from the peripheral terminals initiates a cascade of events that include increased synthesis of nitric oxide and sensitization of the trigeminal nerves. Secreted CGRP in the trigeminal ganglion interacts with adjacent neurons and satellite glial cells to perpetuate peripheral sensitization, and can drive central sensitization of the second‐order neurons. A shift in central sensitization from activity‐dependent to activity‐independent central sensitization may indicate a mechanism driving the progression of episodic migraine to chronic migraine. The pathophysiology of cluster headache is much more obscure than that of migraine, but emerging evidence suggests that it may also involve hypersensitivity of the trigeminovascular system. Ongoing clinical studies with therapies targeted at CGRP will provide additional, valuable insights into the pathophysiology of this disorder. Conclusions: CGRP plays an essential role in the pathophysiology of migraine. Treatments that interfere with the functioning of CGRP in the peripheral trigeminal system are effective against migraine. Blocking sensitization of the trigeminal nerve by attenuating CGRP activity in the periphery may be sufficient to block a migraine attack. Additionally, the potential exists that this therapeutic strategy may also alleviate cluster headache as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Classification of Headache Disorders, 3rd edition (beta version)
Headache Classification Committee of the International Headache Society (IHS) (2013) · Cephalalgia · doi:10.1177/0333102413485658 · Cited by 8,229
Interplay between Cortical Spreading Depolarization and Seizures
Kramer, D. R., Fujii, T., Ohiorhenuan, I., & Liu, C. Y. (2017) · Stereotactic and Functional Neurosurgery · doi:10.1159/000452841 · Cited by 3,696
SPREADING DEPRESSION OF ACTIVITY IN THE CEREBRAL CORTEX
Leao, A. A. P. (1944) · Journal of Neurophysiology · doi:10.1152/jn.1944.7.6.359 · Cited by 2,679
Pathophysiology of migraine: a disorder of sensory processing
Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017) · Physiological Reviews · doi:10.1152/physrev.00034.2015 · Cited by 1,998
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
Goadsby, P. J., Edvinsson, L., & Ekman, R. (1990) · Annals of Neurology · doi:10.1002/ana.410280213 · Cited by 1,597
Mechanisms of migraine aura revealed by functional MRI in human visual cortex
Hadjikhani, N., Sanchez del Rio, M., Wu, O., Schwartz, D., Bakker, D., Fischl, B., Kwong, K. K., Cutrer, F. M., Rosen, B. R., Tootell, R. B. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071582498 · Cited by 1,518
Brain stem activation in spontaneous human migraine attacks
Weiller, C., May, A., Limmroth, V., Jüptner, M., Kaube, H., Schayck, R. V., Coenen, H. H., & Dlener, H. C. (1995) · Nature Medicine · doi:10.1038/nm0795-658 · Cited by 1,384
Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
Russell, F. A., King, R., Smillie, S.-J., Kodji, X., & Brain, S. D. (2014) · Physiological Reviews · doi:10.1152/physrev.00034.2013 · Cited by 1,258
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
Olesen, J., Diener, H.-C., Husstedt, I. W., Goadsby, P. J., Hall, D., Meier, U., Pollentier, S., & Lesko, L. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030505 · Cited by 1,189
Goadsby, P. J., & Edvinsson, L. (1993) · Annals of Neurology · doi:10.1002/ana.410330109 · Cited by 1,158
Pathophysiology of the migraine aura: The spreading depression theory
Lauritzen, M. (1994) · Brain · doi:10.1093/brain/117.1.199 · Cited by 1,151
Hypothalamic activation in cluster headache attacks
May, A., Bahra, A., Büchel, C., Frackowiak, R. S., & Goadsby, P. J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02470-2 · Cited by 1,123
CGRP as the target of new migraine therapies — successful translation from bench to clinic
Edvinsson, L., Haanes, K. A., Warfvinge, K., & Krause, D. N. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0003-1 · Cited by 999
FURTHER OBSERVATIONS ON THE SPREADING DEPRESSION OF ACTIVITY IN THE CEREBRAL CORTEX
Leo, A. A. P. (1947) · Journal of Neurophysiology · doi:10.1152/jn.1947.10.6.409 · Cited by 943
Noseda, R., & Burstein, R. (2013) · Pain · doi:10.1016/j.pain.2013.07.021 · Cited by 871
Goadsby, P. J., Edvinsson, L., & Ekman, R. (1988) · Annals of Neurology · doi:10.1002/ana.410230214 · Cited by 863
Migraine: Multiple Processes, Complex Pathophysiology
Burstein, R., Noseda, R., & Borsook, D. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0373-15.2015 · Cited by 838
RAY, B. S. (1940) · Archives of Surgery · doi:10.1001/archsurg.1940.01210040002001 · Cited by 783
Yarnitsky, D. (2010) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32833c348b · Cited by 745
Tepper, S., Ashina, M., Reuter, U., Brandes, J. L., Doležil, D., Silberstein, S., Winner, P., Leonardi, D., Mikol, D., & Lenz, R. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30083-2 · Cited by 722
Sensitization of meningeal sensory neurons and the origin of headaches
Strassman, A. M., Raymond, S. A., & Burstein, R. (1996) · Nature · doi:10.1038/384560a0 · Cited by 703
Goadsby, P. J., & Edvinsson, L. (1994) · Brain · doi:10.1093/brain/117.3.427 · Cited by 681
Pietrobon, D., & Moskowitz, M. A. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183717 · Cited by 680
Premonitory symptoms in migraine: An electronic diary study
Giffin, N. J., Ruggiero, L., Lipton, R. B., Silberstein, S. D., Tvedskov, J. F., Olesen, J., Altman, J., Goadsby, P. J., & Macrae, A. (2003) · Neurology · doi:10.1212/01.wnl.0000052998.58526.a9 · Cited by 670
Migraine Headache Triggered Specifically by Sunlight: Report of 16 Cases
Tekatas, A., & Mungen, B. (2013) · European Neurology · doi:10.1159/000354165 · Cited by 665
Burstein, R., Yamamura, H., Malick, A., & Strassman, A. M. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.79.2.964 · Cited by 606
Iyengar, S., Ossipov, M. H., & Johnson, K. W. (2017) · Pain · doi:10.1097/j.pain.0000000000000831 · Cited by 584
Self-citationSchulte, L. H., & May, A. (2016) · Brain · doi:10.1093/brain/aww097 · Cited by 582
Timing and topography of cerebral blood flow, aura, and headache during migraine attacks
Olesen, J., Friberg, L., Olsen, T. S., Iversen, H. K., Lassen, N. A., Andersen, A. R., & Karle, A. (1990) · Annals of Neurology · doi:10.1002/ana.410280610 · Cited by 567
Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study
Detke, H. C., Goadsby, P. J., Wang, S., Friedman, D. I., Selzler, K. J., & Aurora, S. K. (2018) · Neurology · doi:10.1212/wnl.0000000000006640 · Cited by 563
Self-citationStauffer, V. L., Dodick, D. W., Zhang, Q., Carter, J. N., Ailani, J., & Conley, R. R. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1212 · Cited by 559
Skljarevski, V., Matharu, M., Millen, B. A., Ossipov, M. H., Kim, B.-K., & Yang, J. Y. (2018) · Cephalalgia · doi:10.1177/0333102418779543 · Cited by 531
Self-citationBrain activations in the premonitory phase of nitroglycerin-triggered migraine attacks
Maniyar, F. H., Sprenger, T., Monteith, T., Schankin, C., & Goadsby, P. J. (2014) · Brain · doi:10.1093/brain/awt320 · Cited by 496
WIMALAWANSA, S. J. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-5-533 · Cited by 494
Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine
Cernuda-Morollón, E., Larrosa, D., Ramón, C., Vega, J., Martínez-Camblor, P., & Pascual, J. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a6cb72 · Cited by 468
Neuropeptides activate human mast cell degranulation and chemokine production
Kulka, M., Sheen, C. H., Tancowny, B. P., Grammer, L. C., & Schleimer, R. P. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02705.x · Cited by 445
Thalamic sensitization transforms localized pain into widespread allodynia
Burstein, R., Jakubowski, M., Garcia‐Nicas, E., Kainz, V., Bajwa, Z., Hargreaves, R., Becerra, L., & Borsook, D. (2010) · Annals of Neurology · doi:10.1002/ana.21994 · Cited by 408
Activation of central trigeminovascular neurons by cortical spreading depression
Zhang, X., Levy, D., Kainz, V., Noseda, R., Jakubowski, M., & Burstein, R. (2011) · Annals of Neurology · doi:10.1002/ana.22329 · Cited by 402
Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
Russo, A. F. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124701 · Cited by 389
Cluster headache: pathogenesis, diagnosis, and management
May, A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67217-0 · Cited by 378
Dodick, D. W., Goadsby, P. J., Silberstein, S. D., Lipton, R. B., Olesen, J., Ashina, M., Wilks, K., Kudrow, D., Kroll, R., Kohrman, B., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70209-1 · Cited by 372
Dodick, D. W., Goadsby, P. J., Spierings, E. L. H., Scherer, J. C., Sweeney, S. P., & Grayzel, D. S. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70128-0 · Cited by 368
Neurogenic inflammation in the pathophysiology and treatment of migraine.
Moskowitz, M. A. (1993) · PubMed · Cited by 363
Deconstructing migraine headache into peripheral and central sensitization
Burstein, R. (2001) · Pain · doi:10.1016/s0304-3959(00)00478-4 · Cited by 362
Sun, H., Dodick, D. W., Silberstein, S., Goadsby, P. J., Reuter, U., Ashina, M., Saper, J., Cady, R., Chon, Y., Dietrich, J., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00019-3 · Cited by 358
Burstein, R., & Jakubowski, M. (2004) · Annals of Neurology · doi:10.1002/ana.10785 · Cited by 357
DURAL HEADACHE AND INNERVATION OF THE DURA MATER
PENFIELD, W. (1940) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1940.02280070051003 · Cited by 349
Functional MRI-BOLD of Visually Triggered Headache in Patients With Migraine
Cao, Y., Welch, K. M. A., Aurora, S., & Vikingstad, E. M. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.548 · Cited by 340
Self-citationMulderry, P. K., Ghatki, M. A., Spokks, R. A., Jonhs, P. M., Pierson, A. M., Hamid, Q. A., Kanse, S., Amara, S. G., Burrik, J. M., Legon, S., et al. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90018-8 · Cited by 333
Eftekhari, S., Salvatore, C. A., Calamari, A., Kane, S. A., Tajti, J., & Edvinsson, L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.016 · Cited by 329
A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks
Thomsen, L. L., Kruuse, C., Iversen, H. K., & Olesen, J. (1994) · European Journal of Neurology · doi:10.1111/j.1468-1331.1994.tb00053.x · Cited by 328
Bernstein, C., & Burstein, R. (2012) · Journal of Clinical Neurology · doi:10.3988/jcn.2012.8.2.89 · Cited by 327
Note on a possible correspondence between the scotomas of migraine and spreading depression of Leão
Milner, P. M. (1958) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(58)90073-7 · Cited by 324
Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention
Lipton, R. B., & Silberstein, S. D. (2015) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12505_2 · Cited by 322
Buzzi, M. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90165-8 · Cited by 318
Neuron–Glia Signaling in Trigeminal Ganglion: Implications for Migraine Pathology
Thalakoti, S., Patil, V. V., Damodaram, S., Vause, C. V., Langford, L. E., Freeman, S. E., & Durham, P. L. (2007) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2007.00854.x · Cited by 308
Marcus, R., Goadsby, P. J., Dodick, D., Stock, D., Manos, G., & Fischer, T. Z. (2014) · Cephalalgia · doi:10.1177/0333102413500727 · Cited by 296
The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine
Edvinsson, L. (2017) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13081 · Cited by 295
Bigal, M. E., Dodick, D. W., Rapoport, A. M., Silberstein, S. D., Ma, Y., Yang, R., Loupe, P. S., Burstein, R., Newman, L. C., & Lipton, R. B. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00249-5 · Cited by 287
Fanciullacci, M., Alessandri, M., Figini, M., Geppetti, P., & Michelacci, S. (1995) · Pain · doi:10.1016/0304-3959(94)00097-x · Cited by 279
Tschopp, F. A., Henke, H., Petermann, J. B., Tobler, P. H., Janzer, R., Hökfelt, T., Lundberg, J. M., Cuello, C., & Fischer, J. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.248 · Cited by 279
Mayberg, M., Langer, R. S., Zervas, N. T., & Moskowitz, M. A. (1981) · Science · doi:10.1126/science.6166046 · Cited by 272
Bigal, M. E., Edvinsson, L., Rapoport, A. M., Lipton, R. B., Spierings, E. L. H., Diener, H.-C., Burstein, R., Loupe, P. S., Ma, Y., Yang, R., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00245-8 · Cited by 261
Eftekhari, S., Warfvinge, K., Blixt, F. W., & Edvinsson, L. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2013.03.010 · Cited by 260
Weidner, C., Klede, M., Rukwied, R., Lischetzki, G., Neisius, U., Schmelz, M., Skov, P. S., & Petersen, L. J. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00142.x · Cited by 257
Magnetoencephalographic fields from patients with spontaneous and induced migraine aura
Bowyer, S. M., Aurora, S. K., Moran, J. E., Tepley, N., & Welch, K. M. A. (2001) · Annals of Neurology · doi:10.1002/ana.1293 · Cited by 251
Self-citationVoss, T., Lipton, R. B., Dodick, D. W., Dupre, N., Ge, J. Y., Bachman, R., Assaid, C., Aurora, S. K., & Michelson, D. (2016) · Cephalalgia · doi:10.1177/0333102416653233 · Cited by 247
Self-citationTriptan‐induced latent sensitization: A possible basis for medication overuse headache
De Felice, M., Ossipov, M. H., Wang, R., Lai, J., Chichorro, J., Meng, I., Dodick, D. W., Vanderah, T. W., Dussor, G., & Porreca, F. (2010) · Annals of Neurology · doi:10.1002/ana.21897 · Cited by 241
Self-citationMedullary pain facilitating neurons mediate allodynia in headache‐related pain
Edelmayer, R. M., Vanderah, T. W., Majuta, L., Zhang, E., Fioravanti, B., De Felice, M., Chichorro, J. G., Ossipov, M. H., King, T., Lai, J., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21537 · Cited by 217
Self-citationDiener, H.-C., Barbanti, P., Dahlöf, C., Reuter, U., Habeck, J., & Podhorna, J. (2011) · Cephalalgia · doi:10.1177/0333102410388435 · Cited by 214
Juhasz, G., Zsombok, T., Jakab, B., Nemeth, J., Szolcsanyi, J., & Bagdy, G. (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2005.00836.x · Cited by 214
Release of Histamine from Dural Mast Cells by Substance P and Calcitonin Gene-Related Peptide
Ottosson, A., & Edvinsson, L. (1997) · Cephalalgia · doi:10.1046/j.1468-2982.1997.1703166.x · Cited by 212
Noseda, R., Jakubowski, M., Kainz, V., Borsook, D., & Burstein, R. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3285-11.2011 · Cited by 210
Lewis, G. N., Luke, H., Rice, D. A., Rome, K., & McNair, P. J. (2012) · Pain Research and Management · doi:10.1155/2012/610561 · Cited by 206
The Occipital Cortex Is Hyperexcitable in Migraine: Experimental Evidence
Aurora, S., Cao, Y., Bowyer, S., & Welch, K. M. A. (1999) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1999.3907469.x · Cited by 194
Self-citationCapuano, A., De Corato, A., Lisi, L., Tringali, G., Navarra, P., & Russo, C. D. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-43 · Cited by 192
Melo-Carrillo, A., Strassman, A. M., Nir, R.-R., Schain, A. J., Noseda, R., Stratton, J., & Burstein, R. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2211-17.2017 · Cited by 189
Hypothalamus as a mediator of chronic migraine: Evidence from high-resolution fMRI
Schulte, L. H., Allers, A., & May, A. (2017) · Neurology · doi:10.1212/wnl.0000000000003963 · Cited by 188
Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine
Recober, A., Kuburas, A., Zhang, Z., Wemmie, J. A., Anderson, M. G., & Russo, A. F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1727-09.2009 · Cited by 186
OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine
Cernuda-Morollón, E., Ramón, C., Martínez-Camblor, P., Serrano-Pertierra, E., Larrosa, D., & Pascual, J. (2015) · Pain · doi:10.1097/j.pain.0000000000000119 · Cited by 181
Ashina, M., Lassen, L., Bendtsen, L., Jensen, R., & Olesen, J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)01079-4 · Cited by 175
Akerman, S., Williamson, D. J., Kaube, H., & Goadsby, P. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704842 · Cited by 175
Fabbretti, E., D'Arco, M., Fabbro, A., Simonetti, M., Nistri, A., & Giniatullin, R. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0647-06.2006 · Cited by 173
A riot of rhythms: neuronal and glial circadian oscillators in the mediobasal hypothalamus
Guilding, C., Hughes, A. T., Brown, T. M., Namvar, S., & Piggins, H. D. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-28 · Cited by 171
An update on migraine: current understanding and future directions
Puledda, F., Messina, R., & Goadsby, P. J. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8434-y · Cited by 168
Nitric Oxide Synthase Inhibition: A New Principle in the Treatment of Migraine Attacks
Lassen, L., Ashina, M., Christiansen, I., Ulrich, V, Grover, R., Donaldson, J., & Olesen, J. (1998) · Cephalalgia · doi:10.1046/j.1468-2982.1998.1801027.x · Cited by 166
Aurora, S. K., & Brin, M. F. (2017) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12999 · Cited by 165
Self-citationMelo-Carrillo, A., Noseda, R., Nir, R.-R., Schain, A. J., Stratton, J., Strassman, A. M., & Burstein, R. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0576-17.2017 · Cited by 163
CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine
Cernuda‐Morollón, E., Martínez‐Camblor, P., Ramón, C., Larrosa, D., Serrano‐Pertierra, E., & Pascual, J. (2014) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12372 · Cited by 161
Eftekhari, S., & Edvinsson, L. I. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-112 · Cited by 160
Dodick, D. W., Goadsby, P. J., Lucas, C., Jensen, R., Bardos, J. N., Martinez, J. M., Zhou, C., Aurora, S. K., Yang, J. Y., Conley, R. R., et al. (2020) · Cephalalgia · doi:10.1177/0333102420905321 · Cited by 160
Self-citationParaventricular Hypothalamic Regulation of Trigeminovascular Mechanisms Involved in Headaches
Robert, C., Bourgeais, L., Arreto, C., Condés‐Lara, M., Noseda, R., Jay, T. M., & Villanueva, L. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0439-13.2013 · Cited by 159
Kruger, L., Sternini, C., Brecha, N. C., & Mantyh, P. W. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902730203 · Cited by 158
Mason, B. N., Kaiser, E. A., Kuburas, A., Loomis, M.-C. M., Latham, J. A., Garcia-Martinez, L. F., & Russo, A. F. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2967-16.2016 · Cited by 158
Hauge, A. W., Asghar, M. S., Schytz, H. W., Christensen, K. B., & Olesen, J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70135-8 · Cited by 157
Iversen, H. K., & Olesen, J. (1996) · Cephalalgia · doi:10.1046/j.1468-2982.1996.1606412.x · Cited by 154
Giniatullin, R. A., Nistri, A., & Fabbretti, E. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8020-5 · Cited by 147
Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks
Vollesen, A. L. H., Snoer, A. H., Beske, R. P., Guo, S., Hoffmann, J., Jensen, R., & Ashina, M. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1675 · Cited by 147
Bellamy, J., Bowen, E. J., Russo, A. F., & Durham, P. L. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04742.x · Cited by 145
Targeted Nitric Oxide Synthase Inhibitors for Migraine
Pradhan, A. A. A., Bertels, Z., & Akerman, S. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0614-7 · Cited by 144
Cady, R. J., Glenn, J. R., Smith, K. M., & Durham, P. L. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-94 · Cited by 143
Recognizing the role of CGRP and CGRP receptors in migraine and its treatment
Edvinsson, L. I., & Warfvinge, K. (2017) · Cephalalgia · doi:10.1177/0333102417736900 · Cited by 141
Cortical spreading depression as a site of origin for migraine: Role of CGRP
Close, L. N., Eftekhari, S., Wang, M., Charles, A. C., & Russo, A. F. (2018) · Cephalalgia · doi:10.1177/0333102418774299 · Cited by 141
Cortical spreading depression induces oxidative stress in the trigeminal nociceptive system
Shatillo, A., Koroleva, K., Giniatullina, R., Naumenko, N. V., Slastnikova, A. A., Aliev, R. R., Bart, G., Atalay, M., Gu, C., Khazipov, R., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.002 · Cited by 140
Charbit, A. R., Akerman, S., Holland, P. R., & Goadsby, P. J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2887-09.2009 · Cited by 139
CGRP and NO in the Trigeminal System: Mechanisms and Role in Headache Generation
Meßlinger, K., Lennerz, J. K., Eberhardt, M. J., & Fischer, M. J. M. (2012) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2012.02212.x · Cited by 136
Fischer, M. J. M., Koulchitsky, S., & Meßlinger, K. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0869-05.2005 · Cited by 134
Cady, R. K., Vause, C. V., Ho, T. W., BIGAL, M. E., & Durham, P. L. (2009) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2009.01523.x · Cited by 133
Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine
Guo, S., Vollesen, A. L. H., Olesen, J., & Ashina, M. (2016) · Pain · doi:10.1097/j.pain.0000000000000702 · Cited by 133
Bowen, E. J., Schmidt, T., Firm, C. S., Russo, A. F., & Durham, P. L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03524.x · Cited by 132
Hostetler, E. D., Joshi, A. D., Bohorquez, S. M. S., Fan, H. S., Zeng, Z., Purcell, M. L., Gantert, L. T., Riffel, K. A., Williams, M., O'Malley, S. S., et al. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.206458 · Cited by 131
Lanepitant, an NK-1 Antagonist, in Migraine Prevention
Dj, G., Offen, W., Klein, E., Phebus, L., Hipskind, P. A., Johnson, K., & RYAN, R. E. (2001) · Cephalalgia · doi:10.1046/j.1468-2982.2001.00161.x · Cited by 130
Self-citationSchwedt, T. J., Larson‐Prior, L. J., Coalson, R. S., Nolan, T. S., Mar, S., Ances, B. M., Benzinger, T. L. S., & Schlaggar, B. L. (2013) · Pain Medicine · doi:10.1111/pme.12267 · Cited by 129
Felice, M. D., Ossipov, M. H., Wang, R., Dussor, G. O., Lai, J., Meng, I. D., Chichorro, J. G., Andrews, J. S., Rakhit, S., Maddaford, S. P., et al. (2010) · Brain · doi:10.1093/brain/awq159 · Cited by 128
Self-citationNeuropeptide Effects in the Trigeminal System: Pathophysiology and Clinical Relevance in Migraine
Meßlinger, K., Fischer, M. J. M., & Lennerz, J. K. (2011) · The Keio Journal of Medicine · doi:10.2302/kjm.60.82 · Cited by 120
Substance P receptor antagonists in the therapy of migraine
May, A., & Goadsby, P. J. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.4.673 · Cited by 119
The CGRP Pathway in Migraine as a Viable Target for Therapies
Edvinsson, L. I. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13305 · Cited by 111
Distribution of CGRP and CGRP receptor components in the rat brain
Warfvinge, K., & Edvinsson, L. I. (2017) · Cephalalgia · doi:10.1177/0333102417728873 · Cited by 108
Modulation of CGRP-Induced Light Aversion in Wild-Type Mice by a 5-HT1B/DAgonist
Kaiser, E. A., Kuburas, A., Recober, A., & Russo, A. F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3265-12.2012 · Cited by 101
Understanding migraine as a cycling brain syndrome: reviewing the evidence from functional imaging
May, A. (2017) · Neurological Sciences · doi:10.1007/s10072-017-2866-0 · Cited by 101
The Neurobiology of Pain Perception in Normal and Persistent Pain
Fenton, B. W., Shih, E., & Zolton, J. R. (2015) · Pain Management · doi:10.2217/pmt.15.27 · Cited by 100
Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patients
Fanciullacci, M. (1997) · Brain · doi:10.1093/brain/120.2.283 · Cited by 99
Possible sites of action of the new calcitonin gene-related peptide receptor antagonists
Eftekhari, S., & Edvinsson, L. I. (2010) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610388343 · Cited by 97
Prostaglandin E 2 induces immediate migraine-like attack in migraine patients without aura
Antonova, M., Wienecke, T., Olesen, J., & Ashina, M. (2012) · Cephalalgia · doi:10.1177/0333102412451360 · Cited by 94
The Perception and Endogenous Modulation of Pain
Ossipov, M. H. (2012) · Scientifica · doi:10.6064/2012/561761 · Cited by 93
Self-citationNeuropeptides Activate Human Mast Cell Degranulation and Chemokine Production
Tancowny, B. P., Sheen, C. H., Grammer, L. C., Schleimer, R. P., & Kulka, M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.274 · Cited by 92
Edvinsson, L. I., Eftekhari, S., Salvatore, C., & Warfvinge, K. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.10.005 · Cited by 85
Effects of sensitization of trigeminovascular neurons to triptan therapy during migraine
Burstein, R., Levy, D., & Jakubowski, M. (2005) · Revue Neurologique · doi:10.1016/s0035-3787(05)85109-4 · Cited by 81
Ramachandran, R., Bhatt, D. K., Ploug, K. B., Hay‐Schmidt, A., Jansen‐Olesen, I., Gupta, S., & Olesen, J. (2013) · Cephalalgia · doi:10.1177/0333102413502735 · Cited by 81
Migraine and cluster headache – the common link
Vollesen, A. L. H., Benemei, S., Cortese, F., Labastida‐Ramírez, A., Marchese, F., Pellesi, L., Romoli, M., Ashina, M., & Lampl, C. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0909-4 · Cited by 77
Kulchitsky, S., Fischer, M., & Meßlinger, K. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01745.x · Cited by 75
Miller, S., Liu, H., Warfvinge, K., Shi, L., Dovlatyan, M., Xu, C., & Edvinsson, L. I. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.04.046 · Cited by 73
Deep in the brain: Changes in subcortical function immediately preceding a migraine attack
Meylakh, N., Marciszewski, K. K., Pietro, F. D., Macefield, V. G., Macey, P. M., & Henderson, L. A. (2018) · Human Brain Mapping · doi:10.1002/hbm.24030 · Cited by 73
Pathophysiology of medication overuse headache: Insights and hypotheses from preclinical studies
Meng, I. D., Dodick, D., Ossipov, M. H., & Porreca, F. (2011) · Cephalalgia · doi:10.1177/0333102411402367 · Cited by 70
Self-citationTaking the Negative View of Current Migraine Treatments: The Unmet Needs
Tfelt‐Hansen, P. C., & Olesen, J. (2012) · CNS Drugs · doi:10.2165/11630590-000000000-00000 · Cited by 67
Bilateral Descending Hypothalamic Projections to the Spinal Trigeminal Nucleus Caudalis in Rats
Abdallah, K., Artola, A., Monconduit, L., Dallel, R., & Luccarini, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073022 · Cited by 67
Koulchitsky, S., Fischer, M. J. M., Col, R. D., Schlechtweg, P. M., & Meßlinger, K. (2004) · Journal of Neurophysiology · doi:10.1152/jn.01210.2003 · Cited by 67
Brain excitability in migraine: evidence from transcranial magnetic stimulation studies
Aurora, S. K., & Welch, K. M. A. (1998) · Current Opinion in Neurology · doi:10.1097/00019052-199806000-00003 · Cited by 66
Self-citationDurham, P. L. (2016) · Current Pain and Headache Reports · doi:10.1007/s11916-016-0578-4 · Cited by 65
Cortical and Subcortical Modulation of Pain
Felice, M. D., & Ossipov, M. H. (2016) · Pain Management · doi:10.2217/pmt.15.63 · Cited by 62
Self-citationEmerging Target-Based Paradigms to Prevent and Treat Migraine
Silberstein, S. D. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.198 · Cited by 60
Felice, M. D., Ossipov, M. H., & Porreca, F. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328346af25 · Cited by 59
Self-citationXu, W., Lundeberg, T., Wang, Y. T., Li, Y., & Yu, L. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00069-1 · Cited by 59
Charles, A. C., & Hansen, J. M. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000193 · Cited by 58
New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors
Hoffmann, J., & Goadsby, P. J. (2011) · Current Treatment Options in Neurology · doi:10.1007/s11940-011-0155-4 · Cited by 57
Yu, L., Hou, J., Fu, F., & Zhang, Y. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.03.009 · Cited by 57
Corato, A. D., Lisi, L., Capuano, A., Tringali, G., Tramutola, A., Navarra, P., & Russo, C. D. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.05.013 · Cited by 57
Reddington, M., Priller, J., Treichel, J., Haas, C. A., & Kreutzberg, G. W. (1995) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y95-148 · Cited by 56
Trigeminal autonomic cephalalgias
Eller, M., & Goadsby, P. J. (2014) · Oral Diseases · doi:10.1111/odi.12263 · Cited by 56
Arngrim, N., Hougaard, A., Ahmadi, K., Vestergaard, M. B., Schytz, H. W., Amin, F. M., Larsson, H. B. W., Olesen, J., Hoffmann, M. B., & Ashina, M. (2017) · Annals of Neurology · doi:10.1002/ana.25096 · Cited by 55
Periaqueductal gray calcitonin gene-related peptide modulates trigeminovascular neurons
Pozo‐Rosich, P., Storer, R. J., Charbit, A. R., & Goadsby, P. J. (2015) · Cephalalgia · doi:10.1177/0333102415576723 · Cited by 54
Eftekhari, S., Salvatore, C., Gaspar, R. C., Roberts, R., O'Malley, S. S., Zeng, Z., & Edvinsson, L. I. (2013) · The Cerebellum · doi:10.1007/s12311-013-0509-4 · Cited by 49
Villanueva, L. (2009) · Pain · doi:10.1016/j.pain.2009.03.003 · Cited by 49
Cornelison, L. E., Hawkins, J. L., & Durham, P. L. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.10.013 · Cited by 47
Drugs targeting nitric oxide synthase for migraine treatment
Barbanti, P., Egeo, G., Aurilia, C., Fofi, L., & Della‐Morte, D. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.918953 · Cited by 45
Calcitonin Gene-Related Peptide-Targeted Therapies for Migraine and Cluster Headache: A Review
Schuster, N. M., & Rapoport, A. M. (2017) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000227 · Cited by 45
Kwok, Y. H., Swift, J. E., Gazerani, P., & Rolan, P. E. (2016) · Journal of Pain Research · doi:10.2147/jpr.s116968 · Cited by 35
Yu, L., Weng, X., Wang, J., et al. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00273-8 · Cited by 33
Durham, Z. L., Hawkins, J. L., & Durham, P. L. (2016) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2016.10.034 · Cited by 27
Peck, K. R., Johnson, Y. L., & Smitherman, T. A. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802973-2.00016-1 · Cited by 26
Cluster headache: present and future therapy
Leone, M., Giustiniani, A., & Cecchini, A. P. (2017) · Neurological Sciences · doi:10.1007/s10072-017-2924-7 · Cited by 18
CGRP: a Multifunctional Neuropeptide
Russo, A. F., & Dickerson, I. M. (2006) · Springer eBooks · doi:10.1007/0-387-30395-2_19 · Cited by 18
Medication overuse reinstates conditioned pain modulation in women with migraine
Guy, N., Voisin, D. L., Mulliez, A., Clavelou, P., & Dallel, R. (2017) · Cephalalgia · doi:10.1177/0333102417727545 · Cited by 16
Yi-hong, Z., Tamada, Y., Akai, K., & Suwa, F. (2006) · Okajimas Folia Anatomica Japonica · doi:10.2535/ofaj.83.91 · Cited by 8
Cited by
Applying a biopsychosocial model to migraine: rationale and clinical implications
Rosignoli, C., Ornello, R., Onofri, A., Caponnetto, V., Grazzi, L., Raggi, A., Leonardi, M., & Sacco, S. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01471-3 · Cited by 138
Research progress in calcitonin gene-related peptide and bone repair
Wang, Q., Qin, H., Deng, J., Xu, H., Liu, S., Weng, J., & Zeng, H. (2023) · Biomolecules · doi:10.3390/biom13050838 · Cited by 58
Naghibi, M. M., Day, R., Stone, S., & Harper, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091441 · Cited by 28
Metadata
- Authors
- Iyengar, S., Johnson, K. W., Ossipov, M. H., & Aurora, S. K.
- Venue
- Headache: The Journal of Head and Face Pain
- Publisher
- Wiley
- Published
- 2019-04-14
- Volume
- 59
- Issue
- 5
- Pages
- 659-681
- ISSN
- 0017-8748 (ISSN-L)
- 1526-4610
- OpenAlex
- W2938743773
- Cited by
- 486
- References
- 166
- FWCI
- 29.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.